Cargando…
Optimising the use of mTOR inhibitors in renal transplantation
Renal transplantation is the treatment of choice for end-stage renal failure. Although advances in immunosuppression have led to improvements in short-term outcomes, graft survival beyond 5 to 10 years has not improved. One of the major causes of late renal allograft failure is chronic allograft nep...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3834524/ https://www.ncbi.nlm.nih.gov/pubmed/24565283 http://dx.doi.org/10.1186/2047-1440-2-S1-S4 |